Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Esophageal Squamous Cell Carcinoma × Ramucirumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 16 Carcinoma, Non-Small-Cell Lung 8 Neoplasm Metastasis 3 Adenocarcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Lung Neoplasms 2 Adenocarcinoma Of Esophagus 2 Thymoma 1 Recurrence 1 Pancreatic Neoplasms 1 Neoplasms 1 Mesothelioma, Malignant 1 Mesothelioma 1 Locally Advanced Unresectable Gastric Adenocarcinoma 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Gastroesophageal Cancer 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Clinical Stage III Gastric Cancer AJCC v8 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Hepatocellular 1 Carcinoid Tumor 1 Brain Neoplasms 1 Advanced Gastric or EGJ Cancer 1 Advanced Gastric Cancer 1 Adenocarcinoma of the Oesophagus 1

Interventions

Cisplatin 73 Radiotherapy 64 Paclitaxel 45 Fluorouracil 35 Carboplatin 33 Drug Therapy 30 Neoadjuvant Therapy 20 toripalimab 17 Surgical Procedures, Operative 15 Radiation 15 Irinotecan 15 Docetaxel 15 tislelizumab 14 camrelizumab 14 Oxaliplatin 14 Esophagectomy 14 sintilimab 13 pembrolizumab 12 130-nm albumin-bound paclitaxel 12 nimotuzumab 11 Cetuximab 11 TP protocol 10 S 1 (combination) 10 Capecitabine 10 apatinib 9 Radiotherapy, Intensity-Modulated 9 Leucovorin 9 Albumin-Bound Paclitaxel 8 nedaplatin 7 anlotinib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03762564 2022-12-08

RAMOS

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Completed

Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡